Oleamide

Oleamide

SCHEMBL1281695

CCCCCCCCC=CCCCCCCCC(N)=O.O=C([O-])CC(C(=O)[O-])S(=O)(=O)O.[Na+].[Na+]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Oleamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.57
SOAT1 P35610 2/20 0.57
MEN1 O00255 1/20 0.57
TP53 P04637 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2C19 P33261 1/20 0.57
KMT2A Q03164 1/20 0.57
KDM4E B2RXH2 2/20 0.54
EPHX2 P34913 1/20 0.53
FABP3 P05413 7/20 0.52
CNR1 P21554 1/20 0.48
SLC6A5 Q9Y345 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oleamide SCHEMBL1281693 1.00 FAAH (0.57) FAAHSOAT1MEN1TP53CYP1A2
Oleamide SCHEMBL1258566 0.94 FAAH (0.51) FAAHSOAT1MEN1TP53CYP1A2
Oleamide SCHEMBL1258565 0.94 FAAH (0.51) FAAHSOAT1MEN1TP53CYP1A2
Oleic Acid SCHEMBL6270897 0.92 FABP3 (0.63) FAAHEPHX2FABP3SLC6A5
Octadecanoic Acid Amide SCHEMBL1262909 0.92 TP53 (0.42) FAAHSOAT1MEN1TP53CYP1A2
SCHEMBL27937334 0.90 FFAR1 (0.55) FAAHSOAT1MEN1TP53CYP1A2
Oleic Acid SCHEMBL5275143 0.90 PPARG (0.57) FAAHCYP1A2CYP3A4CYP2C19KMT2A
Oleic Acid SCHEMBL5275133 0.90 PPARG (0.57) FAAHCYP1A2CYP3A4CYP2C19KMT2A
Dectaflur SCHEMBL28705927 0.89 EPHX2 (0.48) FAAHEPHX2FABP3SLC6A5
Oleyl Alcohol SCHEMBL28032267 0.88 EPHX2 (0.50) EPHX2FABP3CNR1SLC6A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9587173-B2 Chemiluminescent system IMPERIAL TOY LLC (US) 2017-03-07 US claimed
US-20150368555-A1 CHEMILUMINESCENT SYSTEM GREAT ROCK CAPITAL PARTNERS MANAGEMENT, LLC, AS AGENT 2015-12-24 US claimed
US-9109156-B2 Chemiluminescent system IMPERIAL TOY LLC (US) 2015-08-18 US claimed
US-20140166949-A1 Chemiluminescent system GREAT ROCK CAPITAL PARTNERS MANAGEMENT, LLC, AS AGENT 2014-06-19 US claimed
WO-2013102068-A1 CHEMILUMINESCENT SYSTEM MAGGILUME (US) 2013-07-04 WO claimed
US-20130168620-A1 Chemiluminescent system Maggilume, LLC 2013-07-04 US claimed
EP-2316433-A1 Orally disintegrating tablets of flurbiprofen Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) 2011-05-04 EP claimed
WO-2011048564-A2 ORALLY DISINTEGRATING TABLETS OF FLURBIPROFEN ABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETI (TR) 2011-04-28 WO claimed
CN-122060245-A Antistatic resin composition 东邦化学工业株式会社 2026-05-19 CN disclosed
US-20250382556-A1 MODULATION OF THE BRANCHED-CHAIN METABOLITE CONTENT OF FRUITS AND VEGETABLES UNIV MICHIGAN STATE (US) 2025-12-18 US disclosed
EP-4640308-A1 ENVIRONMENTALLY BIODEGRADABLE COMPOSITIONS COMPRISING AN AMINO ACID ADDUCT, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME TRuCapSol LLC (US) 2025-10-29 EP disclosed
US-20250326882-A1 ENVIRONMENTALLY BIODEGRADABLE COMPOSITIONS COMPRISING AN AMINO ACID ADDUCT, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME TRUCAPSOL LLC (US) 2025-10-23 US disclosed
US-20250326884-A1 COMPOSITIONS COMPRISING AMINO ACID ADDUCTS AND HYDROXY SILANES, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME TRUCAPSOL LLC (US) 2025-10-23 US disclosed
EP-4633370-A1 CO-FORMULATION COMPOSITION ACTION PIN (FR) 2025-10-22 EP disclosed
EP-1466582-A1 Hair treatment composition comprising a silylated peptide-silane copolymer Seiwa Kasei Company, Limited (JP) 2004-10-13 EP disclosed
US-20040147647-A1 Polyorganosiloxane micro-emulsion composition and raw material for cosmetics DOW CORNING TORAY SILICONE CO., LTD. (JP) 2004-07-29 US disclosed
EP-1406575-A2 POLYORGANOSILOXANE MICRO-EMULSION COMPOSITION AND RAW MATERIAL FOR COSMETICS Dow Corning Toray Silicone Co.,Ltd. Patent Department (JP) 2004-04-14 EP disclosed
WO-2002094213-A2 POLYORGANOSILOXANE MICRO-EMULSION COMPOSITION AND RAW MATERIAL FOR COSMETICS DOW CORNING TORAY SILICONE CO.,LTD. (JP) 2002-11-28 WO disclosed
EP-0472591-A1 SULFOSUCCINATE DETERGENT COMPOSITION HENKEL CORPORATION (US) 1992-03-04 EP disclosed
WO-1990014411-A1 SULFOSUCCINATE DETERGENT COMPOSITION HENKEL CORPORATION (US) 1990-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326882-A1 ENVIRONMENTALLY BIODEGRADABLE COMPOSITIONS COMPRISING AN AMINO ACID ADDUCT, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME APEH, CD44, ATIC FAAH 1010/4885SOAT1 1377/4885MEN1 3705/4885
US-20250326884-A1 COMPOSITIONS COMPRISING AMINO ACID ADDUCTS AND HYDROXY SILANES, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME QSOX1, SSR3, CCNE2 FAAH 1508/4885SOAT1 2875/4885MEN1 3379/4885
US-20040147647-A1 Polyorganosiloxane micro-emulsion composition and raw material for cosmetics UNG, PHOSPHO1, TPMT FAAH 741/4885SOAT1 456/4885MEN1 2174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.